83 FR 9760 - Advisory Committee on the Medical Uses of Isotopes Renewal Notice

NUCLEAR REGULATORY COMMISSION

Federal Register Volume 83, Issue 45 (March 7, 2018)

[Federal Register Volume 83, Number 45 (Wednesday, March 7, 2018)]
[Notices]
[Pages 9760-9761]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04610]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes Renewal Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: This notice is to announce the renewal of the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI) for a period of 2 
years.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: The U.S. Nuclear Regulatory Commission (NRC) 
has determined that the renewal of the Charter for the Advisory 
Committee on the Medical Uses of Isotopes for the 2 year period 
commencing on March 1, 2018, is in the public interest, in connection 
with duties imposed on the Commission by law. This action is being 
taken in accordance with the Federal Advisory Committee Act, after 
consultation with the Committee Management Secretariat, General 
Services Administration.
    The purpose of the ACMUI is to provide advice to NRC on policy and 
technical issues that arise in regulating the medical use of byproduct 
material for diagnosis and therapy. Responsibilities include providing 
guidance and comments on current and proposed NRC regulations and 
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating 
training and experience of proposed authorized users. The members are 
involved in preliminary discussions of major issues in determining the 
need for changes in NRC policy and regulation to ensure the continued 
safe use of byproduct material. Each member provides technical 
assistance in his/her specific area(s) of expertise, particularly with 
respect to emerging technologies. Members also provide guidance as to 
NRC's role in relation to the responsibilities of other Federal 
agencies as well as of various professional organizations and boards.
    Members of this Committee have demonstrated professional

[[Page 9761]]

qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.

FOR FURTHER INFORMATION CONTACT: Sophie Holiday, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555; Telephone (301) 415-7865; email 
[email protected].

    Dated at Rockville, Maryland, this 1st day of March, 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2018-04610 Filed 3-6-18; 8:45 am]
 BILLING CODE 7590-01-P